Om Power Transmission Limited Received Approval From SEBI

Mumbai (Maharashtra) [India], March 14: Om Power Transmission Limited (Om Power, “The Company”) a power transmission infrastructure engineering, procurement, and construction (“EPC”) company engaged in executing high-voltage (“HV”) and extra-high voltage (“EHV”) transmission lines, substations, underground cabling projects, and providing comprehensive operation and maintenance (“O&M”) services, has received approval with SEBI in preparation for its Initial Public Offering (“IPO”).

The IPO will comprise up to 1,00,00,000 equity shares with a face value of ₹ 10 each, consisting of a Fresh Issue of up to 90,00,000 Equity Shares and an Offer for Sale of up to 10,00,000 Equity Shares.

The Company’s objective is to

(i) Fund capital expenditure requirements of the Company towards the Purchase of machinery and equipment; (ii) Pre-payment or repayment, in part or full, of certain outstanding borrowings availed by the Company;
(iii) Funding long-term working capital requirements of the Company; and (iv) For general corporate purposes.

For the financial year ended 31st March 2025, the Company reported Revenue of ₹ 27,943.51 lakhs, EBITDA of ₹ 3,565.60 lakhs & Profit After Tax (PAT) of ₹ 2,208.48 lakhs.

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More